BACKGROUND AND AIMS: Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored the risk factors of longer DD. METHODS: In total, 3392 IBD patients recorded in the registry of four IBD Italian centres were divided according to the year of diagnosis into a historical cohort [HC: 1955-84] and modern cohort [MC: 1985-2014]. DD, i.e. time lapse between onset of symptoms indicative of IBD and definitive diagnosis, was divided into four sub-periods [0-6, 7-12, 13-24, >24 months], which were correlated with age and disease location/behaviour at diagnosis. RESULTS: Median DD in IBD was 3.0 months, it was significantly [P < 0.0001] higher in Crohn's disease [CD] [7.1 months] than in ulcerative colitis [UC] [2.0 months], and did not differ either between the HC and the MC or over the last three decades. However, the proportion of patients with a DD>24 months was significantly [P < 0.0001] higher in the HC [26.0%] than in the MC [18.2%], and the same trend was evident over the last three decades [1985-94: 19.9%; 1995-2004: 16.4%; 2005-14: 13.9%; P = 0.04]. At logistic regression analysis, age at diagnosis >40 years (CD: odds ratio 1.73, 95% confidence interval [CI] 1.31-2.28, P < 0.0001; UC: 1.41, 95% CI 1.02-1.96, P = 0.04) and complicated disease at CD diagnosis [1.39, 95% CI 1.06-1.82, P = 0.02] were independently associated with a DD>24 months. CONCLUSIONS: DD duration has not changed over the last 60 years in Italy, but the number of IBD patients with a longer DD significantly decreased. Older age at diagnosis and a complicated disease at CD diagnosis are risk factors for longer DD.
BACKGROUND AND AIMS: Inflammatory bowel disease [IBD] patients are still under-diagnosed or diagnosed with serious delay. We examined whether diagnostic delay [DD] in IBD has changed over the last 60 years, and explored the risk factors of longer DD. METHODS: In total, 3392 IBD patients recorded in the registry of four IBD Italian centres were divided according to the year of diagnosis into a historical cohort [HC: 1955-84] and modern cohort [MC: 1985-2014]. DD, i.e. time lapse between onset of symptoms indicative of IBD and definitive diagnosis, was divided into four sub-periods [0-6, 7-12, 13-24, >24 months], which were correlated with age and disease location/behaviour at diagnosis. RESULTS: Median DD in IBD was 3.0 months, it was significantly [P < 0.0001] higher in Crohn's disease [CD] [7.1 months] than in ulcerative colitis [UC] [2.0 months], and did not differ either between the HC and the MC or over the last three decades. However, the proportion of patients with a DD>24 months was significantly [P < 0.0001] higher in the HC [26.0%] than in the MC [18.2%], and the same trend was evident over the last three decades [1985-94: 19.9%; 1995-2004: 16.4%; 2005-14: 13.9%; P = 0.04]. At logistic regression analysis, age at diagnosis >40 years (CD: odds ratio 1.73, 95% confidence interval [CI] 1.31-2.28, P < 0.0001; UC: 1.41, 95% CI 1.02-1.96, P = 0.04) and complicated disease at CD diagnosis [1.39, 95% CI 1.06-1.82, P = 0.02] were independently associated with a DD>24 months. CONCLUSIONS: DD duration has not changed over the last 60 years in Italy, but the number of IBD patients with a longer DD significantly decreased. Older age at diagnosis and a complicated disease at CD diagnosis are risk factors for longer DD.
Authors: Gottfried Novacek; Hans Peter Gröchenig; Thomas Haas; Heimo Wenzl; Pius Steiner; Robert Koch; Thomas Feichtenschlager; Gerald Eckhardt; Andreas Mayer; Andreas Kirchgatterer; Othmar Ludwiczek; Reingard Platzer; Pavol Papay; Johanna Gartner; Harry Fuchssteiner; Wolfgang Miehsler; Paul-Gerhard Peters; Gerhard Reicht; Harald Vogelsang; Clemens Dejaco; Thomas Waldhör Journal: Wien Klin Wochenschr Date: 2019-02-04 Impact factor: 1.704
Authors: Darcy Güngör; Perrine Nadaud; Carol Dreibelbis; Concetta C LaPergola; Yat Ping Wong; Nancy Terry; Steve A Abrams; Leila Beker; Tova Jacobovits; Kirsi M Järvinen; Laurie A Nommsen-Rivers; Kimberly O O'Brien; Emily Oken; Rafael Pérez-Escamilla; Ekhard E Ziegler; Joanne M Spahn Journal: Am J Clin Nutr Date: 2019-03-01 Impact factor: 7.045
Authors: Ben Hamilton; Harry Green; Neel Heerasing; Peter Hendy; Lucy Moore; Neil Chanchlani; Gareth Walker; Claire Bewshea; Nicholas A Kennedy; Tariq Ahmad; James Goodhand Journal: Frontline Gastroenterol Date: 2020-06-24
Authors: Laura Cantoro; Marco Vincenzo Lenti; Rita Monterubbianesi; Michele Cicala; Diana Giannarelli; Claudio Papi; Anna Kohn; Antonio Di Sabatino Journal: United European Gastroenterol J Date: 2019-06-19 Impact factor: 4.623
Authors: Amanda D Williams; Olga Y Korolkova; Amos M Sakwe; Timothy M Geiger; Samuel D James; Roberta L Muldoon; Alan J Herline; J Shawn Goodwin; Michael G Izban; Mary K Washington; Duane T Smoot; Billy R Ballard; Maria Gazouli; Amosy E M'Koma Journal: PLoS One Date: 2017-08-17 Impact factor: 3.240
Authors: María Chaparro; Ana Garre; Andrea Núñez Ortiz; María Teresa Diz-Lois Palomares; Cristina Rodríguez; Sabino Riestra; Milagros Vela; José Manuel Benítez; Estela Fernández Salgado; Eugenia Sánchez Rodríguez; Vicent Hernández; Rocío Ferreiro-Iglesias; Ángel Ponferrada Díaz; Jesús Barrio; José María Huguet; Beatriz Sicilia; María Dolores Martín-Arranz; Xavier Calvet; Daniel Ginard; Inmaculada Alonso-Abreu; Luis Fernández-Salazar; Pilar Varela Trastoy; Montserrat Rivero; Isabel Vera-Mendoza; Pablo Vega; Pablo Navarro; Mónica Sierra; José Luis Cabriada; Mariam Aguas; Raquel Vicente; Mercè Navarro-Llavat; Ana Echarri; Fernando Gomollón; Elena Guerra Del Río; Concepción Piñero; María José Casanova; Katerina Spicakova; Jone Ortiz de Zarate; Emilio Torrella Cortés; Ana Gutiérrez; Horacio Alonso-Galán; Álvaro Hernández-Martínez; José Miguel Marrero; Rufo Lorente Poyatos; Margalida Calafat; Lidia Martí Romero; Pilar Robledo; Orencio Bosch; Nuria Jiménez; María Esteve Comas; José María Duque; Ana María Fuentes Coronel; Manuela Josefa Sampedro; Eva Sesé Abizanda; Belén Herreros Martínez; Liliana Pozzati; Hipólito Fernández Rosáenz; Belén Crespo Suarez; Pilar López Serrano; Alfredo J Lucendo; Margarita Muñoz Vicente; Fernando Bermejo; José Joaquín Ramírez Palanca; Margarita Menacho; Amalia Carmona; Raquel Camargo; Sandra Torra Alsina; Nuria Maroto; Juan Nerín de la Puerta; Elena Castro; Ignacio Marín-Jiménez; Belén Botella; Amparo Sapiña; Noelia Cruz; José Luis F Forcelledo; Abdel Bouhmidi; Carlos Castaño-Milla; Verónica Opio; Isabel Nicolás; Marcos Kutz; Alfredo Abraldes Bechiarelli; Jordi Gordillo; Yolanda Ber; Yolanda Torres Domínguez; María Teresa Novella Durán; Silvia Rodríguez Mondéjar; Francisco J Martínez-Cerezo; Lilyan Kolle; Miriam Sabat; Cesar Ledezma; Eduardo Iyo; Óscar Roncero; Rebeca Irisarri; Laia Lluis; Isabel Blázquez Gómez; Eva María Zapata; María José Alcalá; Cristina Martínez Pascual; María Montealegre; Laura Mata; Ana Monrobel; Alejandro Hernández Camba; Luis Hernández; María Tejada; Alberto Mir; María Luisa Galve; Marta Soler; Daniel Hervías; José Antonio Gómez-Valero; Manuel Barreiro-de Acosta; Fernando Rodríguez-Artalejo; Esther García-Esquinas; Javier P Gisbert Journal: J Clin Med Date: 2021-06-29 Impact factor: 4.964